Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Capizzi

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Cancer Treatment Reports|February 1, 1987
Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association StudyJ B Craig, B L Powell, D V Jackson, et al.
Cancer Treatment Reports|January 1, 1983
Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ)R W Carey, R L Comis, D Anbar, et al.
Leukemia|December 1, 1991
Leukapheresis induced changes in cell cycle distribution and nucleoside transporters in patients with untreated acute myeloid leukemiaB L Powell, B W Gregory, J K Evans, et al.
Leukemia|May 1, 1990
Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginaseB L Powell, T E Kute, J B Craig, et al.
Leukemia|July 1, 1991
S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cellsB L Powell, J C White, B W Gregory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B StudyR L Capizzi, R Davis, B Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology AssociationH B Muss, L D Case, R L Capizzi, et al.
The New England Journal of Medicine|November 7, 1991
Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology AssociationH B Muss, L D Case, F Richards, et al.
Investigational New Drugs|February 1, 1990
A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphomaH B Muss, N Spell, D Scudiery, et al.
Seminars in Oncology|June 1, 1985
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignanciesH B Muss, R L Capizzi, J N Atkins, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reports|February 1, 1987
Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association StudyJ B Craig, B L Powell, D V Jackson, et al.
Cancer Treatment Reports|January 1, 1983
Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ)R W Carey, R L Comis, D Anbar, et al.
Leukemia|December 1, 1991
Leukapheresis induced changes in cell cycle distribution and nucleoside transporters in patients with untreated acute myeloid leukemiaB L Powell, B W Gregory, J K Evans, et al.
Leukemia|May 1, 1990
Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginaseB L Powell, T E Kute, J B Craig, et al.
Leukemia|July 1, 1991
S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cellsB L Powell, J C White, B W Gregory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B StudyR L Capizzi, R Davis, B Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology AssociationH B Muss, L D Case, R L Capizzi, et al.
The New England Journal of Medicine|November 7, 1991
Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology AssociationH B Muss, L D Case, F Richards, et al.
Investigational New Drugs|February 1, 1990
A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphomaH B Muss, N Spell, D Scudiery, et al.
Seminars in Oncology|June 1, 1985
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignanciesH B Muss, R L Capizzi, J N Atkins, et al.
Pageof 13